Mondaq USA: Food, Drugs, Healthcare, Life Sciences > Food and Drugs Law
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Welcome to the third week of this four week stretch. This week, the House will continue to vote on a number of proposals to address the opioid crisis.
Foley & Lardner
As we noted in this article on PTAB Trial Insights, Senator Hatch (R-UT) has introduced the Hatch-Waxman Integrity Act, which is intended to restore the brand-generic balance ...
Foley & Lardner
Similar requirements also would pertain to Paragraph VIII carve-out certifications.
BakerHostetler
The House last week approved 38 bills that lawmakers hope will stem the opioid epidemic, and it scheduled votes this week on at least a dozen more
Troutman Sanders LLP
The United States Food and Drug Administration recently obtained summary judgment on several cigar industry claims challenging the FDA's Deeming Regulations.
Marshall, Gerstein & Borun LLP
In Vanda Pharmaceuticals, Inc. v. West-Ward Pharmaceuticals, Ltd., Nos. 2016-2707, 2016-2708 (Fed. Cir. April 13, 2018), the court held that claims to methods of treatment were patent eligible.
Reed Smith
Permit us to recount a recent travel misadventure, though whatever eventual connection we draw to today's case will be specious at best. Last Friday, we traveled from Philadelphia to Hartford, Connecticut for a deposition.
Holland & Knight
On June 12, 2018, the U.S. Food and Drug Administration (FDA) released draft guidance entitled "Drug and Device Manufacturer Communications With Payors, Formulary Committees ...
Reed Smith
On this date 46 years ago, President Nixon and his aides had a conversation about the Watergate break-in and cover-up.
Proskauer Rose LLP
Earlier this month, San Francisco's Public Safety & Neighborhood Services Committee unanimously approved an ordinance that requires certain cannabis business permit applicants to agree to enter into a collective bargaining agreement (a "Labor Peace Agreement") with a "Bona Fide Labor Organization" as a condition of receiving a cannabis business permit.
Seyfarth Shaw LLP
Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana.
Reed Smith
You're likely all familiar with the phrase, "don't look a gift horse in the mouth."
Arnold & Porter
The advertising of medicinal products in the UK is controlled by a combination of legislation and codes of practice.
Foley & Lardner
On June 13, 2018, Sen. Hatch (R-Utah) introduced an amendment that would require generic ANDA filers to choose ...
Reed Smith
You'll have to excuse us a bit today.
Lowndes, Drosdick, Doster, Kantor & Reed, P.A.
The recent Tax Court decision, Alterman v. Commissioner, struck yet another tax blow against the growing medical marijuana industry.
Ropes & Gray LLP
The changes to the guidance documents are extensive, but generally provide additional flexibility for manufacturers to convey certain types of product information.
Reed Smith
The MDL court in the Testosterone Replacement Therapy litigation recently entered summary judgment in favor of a non-US manufacturer that did not distribute in the US, along with its US subsidiary.
Arnold & Porter
On June 12, 2018, the US FDA issued revised, final versions of two guidance documents, "Drug and Device Manufacturer Communications with Payors, Formulary Committees and Similar Entities—Questions and Answers"...
Reed Smith
Nothing else works very well at treating Alzheimer's disease.
Latest Video
Most Popular Recent Articles
Shearman & Sterling LLP
This past year has seen renewed challenges to reverse payment settlement agreements in the pharmaceutical industry.
Singh & Associates
An experimental drug derived from cannabis is well poised to become the first of its kind drug to win approval from the United States Food and Drug Administration (USFDA).
Wilson Elser Moskowitz Edelman & Dicker LLP
Also named is SC Laboratories Inc., the logo of which appears on the vape cartigage product's packaging.
McDermott Will & Emery
On April 30, 2018, the U.S. District Court for the District of Massachusetts dismissed the last remaining state FCA claims against long-term care pharmacy provider PharMerica, Inc. on the grounds that neither relator...
Holland & Knight
On April 30, 2018, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) issued a favorable Advisory Opinion No. 18-02 regarding the provision of sample ostomy products...
Seyfarth Shaw LLP
California's AB 2069, a bill to require employers to accommodate medical cannabis users, recently failed to advance past committee.
Davis & Gilbert
The U.S. Food and Drug Administration (FDA) and class action bar are continuing to pursue enforcement and litigation against food and dietary supplement manufacturers who make drug claims ...
Akin Gump Strauss Hauer & Feld LLP
Washington saw a flurry of bipartisan activity over the last few weeks. Most notably, Republican and Democratic negotiators reached a long-awaited deal on sequestration budget caps.
Davis & Gilbert
In late 2017, the U.S. Food and Drug Administration (FDA) officially withdrew Import Alert 66-38, "Skin Care Products Labeled as Anti-Aging Creams"...
Seyfarth Shaw LLP
On November 8, 2016, Maine voters approved "Question 1 – An Act to Legalize Marijuana," and joined a handful of other states, including California, to have legalized the recreational use...
Article Search Using Filters
Related Topics
Mondaq Advice Center (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with